These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3192223)

  • 1. Metabolic activation of carcinogens and toxic chemicals.
    Parke DV; Ioannides C; Lewis DF
    Hum Toxicol; 1988 Sep; 7(5):397-404. PubMed ID: 3192223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active metabolites in toxicology: the role of cytochrome P-448 and flavoprotein oxidases.
    Parke DV; Ioannides C
    Arch Toxicol Suppl; 1984; 7():183-92. PubMed ID: 6595982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation mechanisms to chemical toxicity.
    Parke DV
    Arch Toxicol; 1987; 60(1-3):5-15. PubMed ID: 3304217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of chemical carcinogenicity from molecular and electronic structures: a comparison of MINDO/3 and CNDO/2 molecular orbital methods.
    Lewis DF; Ioannides C; Parke DV
    Toxicol Lett; 1989 Jan; 45(1):1-13. PubMed ID: 2644723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals.
    Parke DV; Ioannides C; Lewis DF
    Can J Physiol Pharmacol; 1991 May; 69(5):537-49. PubMed ID: 1863904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular orbital studies of oxygen activation and mechanisms of cytochromes P-450-mediated oxidative metabolism of xenobiotics.
    Lewis DF; Ioannides C; Parke DV
    Chem Biol Interact; 1989; 70(3-4):263-80. PubMed ID: 2743473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biotransformation in occupational medicine: the role of hepatic cytochrome P-450 in the mechanism of action and the biological monitoring of occupational toxic compounds].
    Manno M; Saia B
    Med Lav; 1994; 85(1):11-21. PubMed ID: 8035741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P-448 and the activation of toxic chemicals and carcinogens.
    Ioannides C; Lum PY; Parke DV
    Xenobiotica; 1984; 14(1-2):119-37. PubMed ID: 6719936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple method for assessment of rat cytochrome P-448 isozymes responsible for the mutagenic activation of carcinogenic chemicals.
    Degawa M; Ueno H; Miura S; Ohta A; Namiki M
    Mutat Res; 1988 Oct; 203(5):333-8. PubMed ID: 3173384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of xenobiotics metabolism, genotoxicity, and carcinogenicity using Cyp2e1(-/-) mice.
    Ghanayem BI; Hoffler U
    Curr Drug Metab; 2007 Oct; 8(7):728-49. PubMed ID: 17979661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol interactions with other cytochrome P450 substrates including drugs, xenobiotics, and carcinogens.
    Djordjević D; Nikolić J; Stefanović V
    Pathol Biol (Paris); 1998 Dec; 46(10):760-70. PubMed ID: 9922992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytochromes P450 in metabolism of carcinogenic aristolochic acid I: evidence of their contribution to aristolochic acid I detoxication and activation in rat liver.
    Stiborova M; Mares J; Levova K; Pavlickova J; Barta F; Hodek P; Frei E; Schmeiser HH
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():121-30. PubMed ID: 22167220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evaluation of COMPACT, the molecular orbital approach for the prospective safety evaluation of chemicals.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1998 Jan; 412(1):41-54. PubMed ID: 9508363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a novel molecular orbital approach (COMPACT) for the prospective safety evaluation of chemicals, by comparison with rodent carcinogenicity and Salmonella mutagenicity data evaluated by the U.S. NCI/NTP.
    Lewis DF; Ioannides C; Parke DV
    Mutat Res; 1993 Feb; 291(1):61-77. PubMed ID: 7678916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsomal metabolism of 2-acetylaminofluorene, role in mutagenicity and carcinogenicity.
    Roberfroid M; Razzouk C; Agazzi-Léonard E; Batardy-Grégoire M; Poncelet F; Mercier M
    Adv Exp Med Biol; 1981; 136 Pt B():921-9. PubMed ID: 7344520
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic activation of dimethylnitrosamine to mutagens: role of cytochromes P-450 and P-448.
    Phillipson CE; Ioannides C; Parke DV
    Toxicol Lett; 1982 Apr; 11(1-2):95-101. PubMed ID: 7046142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytochromes P-448--a unique family of enzymes involved in chemical toxicity and carcinogenesis.
    Ioannides C; Parke DV
    Biochem Pharmacol; 1987 Dec; 36(24):4197-207. PubMed ID: 3318843
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of computers in the safety evaluation of drugs and other chemicals.
    Ioannides C; Lewis DF; Parke DV
    Eur J Drug Metab Pharmacokinet; 1994; 19(3):225-33. PubMed ID: 7867665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of N-acetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds.
    De Flora S; Bennicelli C; Camoirano A; Serra D; Romano M; Rossi GA; Morelli A; De Flora A
    Carcinogenesis; 1985 Dec; 6(12):1735-45. PubMed ID: 3905042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.